ETERNAL's recent final official project dissemination event provided project partners and external guests alike an opportunity to reflect upon and celebrate notable progress made during four years of collaborative research and scale-up for sustainable development of pharmaceutical manufacture, use and disposal, along with notable contributions towards building the the EU’s knowledge base informing environmental risk and ecotoxicity assessemts of pharamceuticals on the one hand and policy development on the other.

A further Public Deliverable summarizing ETERNAL's Change Labs Impacts is now available to download.

We are excited to share the news that ETERNAL's "remarkable contribution to standardization through the development of two CWAs" has been recognised by a nomination in the Project Award category for the Standards+Innovation Awards 2026.